Stephen Oh, MD, PhD

Stephen Oh, MD, PhD

Hematologist

Primary Academic Title

Professor of Medicine and Pathology and Immunology, Co-Chief, Division of Hematology, WashU Medicine

Clinical Expertise

Hematology, myeloproliferative neoplasms

Research Interest

Pathogenesis of myeloproliferative neoplasms (MPNs), the initiation, development, and progression of MPNs, utilizing patient samples and animal models to interrogate dysregulated cytokine-signaling networks in MPNs

Education

  • 2002: PhD, cancer biology, Northwestern University, Chicago
  • 2004: MD, Northwestern University

Training

  • 2004 - 2006: Resident, internal medicine, Stanford University, Stanford, Calif.
  • 2006 - 2010: Fellow, hematology/oncology, Stanford University

Board Certification

  • 2007: American Board of Internal Medicine, Internal Medicine
  • 2010: American Board of Internal Medicine, Hematology

Selected Research Publications

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial.
  • Rampal RK, Grosicki S, Chraniuk D, [...] Oh ST, [...] Mascarenhas J
  • Nat Med 2025
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.
  • Jacoby MA, Duncavage ED, Khanna A, [...] Oh ST, [...] Walter MJ
  • Leukemia 2025
RSK1 dependency in FLT3-ITD acute myeloid leukemia.
  • Kong T, Laranjeira ABA, Letson CT, [...] Oh ST
  • Blood Cancer J 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.
  • Tran D, Beeler JS, Liu J, [...] Oh ST, [...] Bolton KL
  • Clin Cancer Res 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.
  • Gotlib J, Gerds AT, Abdelmessieh P, [...] Oh S, [...] Hochstetler C
  • J Natl Compr Canc Netw 2024

View All Publications

Contact Information

  • Gary C. Werths Building at Siteman Cancer Center

    4500 Forest Park Avenue
    Saint Louis, MO 63108

Phone Numbers

Request an appointment